Mortality attributable to tobacco among men in Sweden and other European countries: an analysis of data in a WHO report

Tobacco Induced Diseases

Tom Wikmans²  Lars Ramström¹ 

[1] Institute for Tobacco Studies, Kanalvägen 17, Täby, 18338, Sweden;Liqusa Research, Åtvidaberg, Sweden

关键词: Europe;    Sweden;    Smoking;    Snus;    Mortality;   

Others  :  1135289
DOI  :  10.1186/1617-9625-12-14

 received in 2014-04-24, accepted in 2014-08-28,  发布年份 2014

【 摘 要 】

Background

It is well known that Swedish men have lower tobacco-related mortality than men in other European countries, but there are questions that need further investigation to what extent this is related to the specific patterns of tobacco use in Sweden, where use of snus, the Swedish low-nitrosamine oral tobacco, dominates over smoking in men but not in women. The recent WHO Global Report: Mortality Attributable to Tobacco provides a unique set of estimates of the health burden of tobacco in all countries of the world in the year 2004, and these data can help elucidating the above-mentioned questions.

Methods

For Sweden and all other European Union Member States mortality data for a number of tobacco-related causes of death were extracted from the WHO Report. The size of the mortality advantage for selected causes of death in different age groups of Swedish men compared to men of the same age in Europe as a whole was calculated in terms of ratios of death rates attributable to tobacco. Differences between age groups with respect to tobacco-related mortality were analyzed with respect to differences in terms of development and status of smoking and snus use. The analyses also paid attention to differences between countries regarding tobacco control regulations.

Findings

Among men in the European Union Member States the lowest level of mortality attributable to tobacco was consistently found in Sweden, while Swedish women showed levels similar to European average. A strong co-variation was found between the mortality advantage and the degree of dominance of snus use in the different age groups of Swedish men. Among Swedish women there are no age groups with dominant use of snus, and similar observations were therefore not possible for women.

Conclusion

The above findings support the assumption that the widespread use of snus instead of cigarettes among Swedish men may be a major part of the explanation behind their position with Europe’s lowest mortality attributable to tobacco.

【 授权许可】

   
2014 Ramström and Wikmans; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Zatoński W, Przewoźniak K, Sulkowska U, West R, Wojtyła A: Tobacco smoking in countries of the European Union. Ann Agric Environ Med 2012, 19(2):181-192.
• [2]World Health Organization: WHO Global Report: Mortality Attributable to Tobacco. Geneva; 2012. Available from: http://www.who.int/tobacco/publications/surveillance/rep_mortality_attibutable/en/index.html webcite accessed on 07/08/14
• [3]Statistics Sweden: Use of alcohol and tobacco. Report no 114, Living Conditions. Stockholm; 2007. Available from: http://www.scb.se/statistik/_publikationer/LE0101_2004I05_BR_LE114SA0701.pdf webcite accessed on 07/08/14
• [4]Joossens L, Raw M: The Tobacco Control Scale 2010 in Europe. Brussels: Association of European Cancer Leagues; 2011. Available from: http://www.europeancancerleagues.org/images/stories/The_TCS_2010_in_Europe_Final_4.pdf webcite
• [5]Foulds J, Ramström L, Burke M, Fagerström K: Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003, 12:349-359.
• [6]Engholm G, Ferlay J, Christensen N, Johannesen TB, Khan S, Køtlum JE, Milter MC, Olafsdóttir E, Pukkala E, Storm HH: NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 6.1 (25.04.2014). Association of the Nordic Cancer Registries. Danish Cancer Society; Available from: http://www.ancr.nu webcite accessed on 07/08/14
• [7]Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino G, Hyland A, Sweanor D, Warner KE: The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev 2004, 13:2035-2042.
• [8]Gartner CE, Hall WH, Vos TH, Bertram MY, Wallace AL, Lim SS: Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 2007, 369:2010-2014.
• [9]European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Harm reduction: evidence, impacts and challenges. EMCDDA scientific monograph No.10. Lisbon: EMCDDA; 2010.
• [10]Ramström LM, Foulds J: Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control 2006, 15:210-214.
• [11]Furberg H, Bulik CM, Lerman C, Lichtenstein P, Pedersen NL, Sullivan PF: Is Swedish snus associated with smoking initiation or smoking cessation? Tob Control 2005, 14:422-424.
• [12]Galanti MR, Rosendahl I, Wickholm S: The development of tobacco use in adolescence among “snus starters” and “cigarette starters”: An analysis of the Swedish “BROMS” cohort. Nicotine Tob Res 2008, 10:315-323.
• [13]Stenbeck M, Hagquist C, Rosén M: The association of snus and smoking behaviour: a cohort analysis of Swedish males in the 1990s. Addiction 2009, 104:1579-1585.
• [14]Foulds J, Kozlowski L: Snus — what should the public-health response be? Lancet 2007, 369:1976-1978.